OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding
Open Access
- 16 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 23 (11) , 849-858
Abstract
Antibodies are an important class of proteins with many biomedical and biotechnical applications. Although there are a plethora of experimental techniques geared toward their efficient production, there is a paucity of computational methods for their de novo design. OptCDR is a general computational method to design the binding portions of antibodies to have high specificity and affinity against any targeted epitope of an antigen. First, combinations of canonical structures for the antibody complementarity determining regions (CDRs) that are most likely to be able to favorably bind the antigen are selected. This is followed by the simultaneous refinement of the CDR structures' backbones and optimal amino acid selection for each position. OptCDR is applied to three computational test cases: a peptide from the capsid of hepatitis C, the hapten fluorescein and the protein vascular endothelial growth factor. The results demonstrate that OptCDR can efficiently generate diverse antibody libraries of a pre-specified size with promising antigen affinity potential as exemplified by computationally derived binding metrics.Keywords
This publication has 43 references indexed in Scilit:
- Computational design of Candida boidinii xylose reductase for altered cofactor specificityProtein Science, 2009
- OptGraft: A computational procedure for transferring a binding site onto an existing protein scaffoldProtein Science, 2008
- Toward high‐resolution homology modeling of antibody Fv regions and application to antibody–antigen dockingProteins: Structure, Function, and Bioinformatics, 2008
- Affinity maturation of antibodies assisted byin silicomodelingProceedings of the National Academy of Sciences, 2008
- Computational design of antibody-affinity improvement beyond in vivo maturationNature Biotechnology, 2007
- Extending Iterative Protein Redesign and Optimization (IPRO) in Protein Library Design for Ligand SpecificityBiophysical Journal, 2007
- In vitro evolution of single-chain antibodies using mRNA displayNucleic Acids Research, 2006
- Affinity enhancement of an in vivo matured therapeutic antibody using structure‐based computational designProtein Science, 2006
- The Protein Data BankNucleic Acids Research, 2000
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999